GreenMCMeds (GMCM) research is a full-service, clinical research company that drives and accelerates enrollment for U.S. and global clinical studies. We provide comprehensive services for conducting clinical research studies for geneticists, pharmaceutical, biotechnology, consumer healthcare and medical device companies in a range of therapeutic areas.
Currently, our network has expanded our database to over 10,000 physicians. GMCM is culturally competent and maintains the highest ethical standards adhering to Good Clinical Practices (GCP) throughout the drug development process. Sensitivity to diverse, social, religious and cultural beliefs has allowed GMCM to overcome the many challenges of diverse recruitment.
GMCM primary goals are to eliminate disparities in clinical research. Committed to a continuous expansion of the network of physicians, to offer the experienced as well as the inexperienced investigators an opportunity to develop, enhance, and support clinical trials within their practice.
Conducting evidence-based studies that yield quality data, which ultimately provide the physician and any healthcare organization with a comprehensive research plan for their patients. GMCM embraces the importance of diversity in clinical research, while enhancing the quality of life for all populations who benefit from personalized medicine and/or traditional medicine.
The advancement of personalized preventative care is at the heart of clinical research. GMCM research is further supported by various marketing strategies that promote the collection of quality data and the development of a patient-centered software.
GMCM is committed to scientific integrity, patient support services, education and mentoring of experienced and inexperienced medical staff while collecting quality patient data through a Personalized Medical Tracking System (PMTS) and Quality Assurance (QA) Program. Collectively, these tools will aid the planning, development, implementation and evaluation of standard of care for all subjects receiving personalized medicine.
Allows the research department to implement strategies and processes that adheres to compliant behavior in the following areas:
GMCM has developed and implemented a diverse physician network, whereby the company has recruited, educated, trained and provided a clinical research infrastructure to physicians in various private practice specialties.
Decades of scientific advancement have dramatically improved patient care and treatment. Genetic studies enhanced the physician’s ability to make an accurate diagnosis and prescribe appropriate treatment. GMCM is among one of the first clinical research companies that made personalized preventative medicine a cornerstone.
Personalized preventative genetic services and holistic educational resources of GreenMCMeds complemented the hospitals' and clinics’ resources and stimulated growth in global clinical research. Today, the development of new procedures, technologies, as well as fundamental research, continue to be an integral part of GMCM’ mission of excellence in patient care.
Today, with shorter and more intensive hospital/clinic visits and a shift to outpatient care, it’s even more important to provide programs and services for personalizing and prevention to treat the whole patient through education that they expect and need for participation in their personalized care.
At the timing of your convenience, GreenMCMeds welcomes the opportunity to further discuss and explore how to best assist the evolving personalized and preventative healthcare industry in our healthcare communities utilizing clinical research with your support. A partnership with GMCM commitment, passion, sensitivity, skills and expertise creates a unique opportunity to perfect this medicine for our patients to whom we serve.
DISCLAIMER: GreenMCMeds does not partake in cultivation or dispensing of cannabis in no way, shape, or form, nor are we affiliated with any dispensaries or cultivation sites.